This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Protalix BioTherapeutics Inc (PLX)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 76.37M 54.77M 86.40M 52.03M
Receivables 0.00 1.88M 2.09M 1.41M
Inventories 5.77M 6.67M 7.96M 4.04M
Other Current Assets 3.74M 1.42M 1.46M 3.14M
Total Current Assets 85.88M 65.52M 97.90M 61.17M
Property, Plant & Equipment, Gross 33.55M 32.74M 32.03M 31.10M
Accumulated Depreciation & Depletion 23.80M 21.45M 18.32M 14.79M
Property, Plant & Equipment, Net 9.74M 11.28M 13.71M 16.31M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.63M 1.67M 1.72M 1.25M
Total Non-Current Assets 11.37M 12.95M 15.43M 17.56M
Liabilities & Shareholder Equity
Total Assets 97.25M 78.47M 113.33M 78.73M
Accounts Payable 3.66M 4.45M 17.33M 6.83M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 3.46M 7.75M 0.00 5.71M
Total Current Liabilities 11.23M 26.21M 26.70M 25.75M
Long Term Debt 72.10M 67.46M 67.05M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 3.05M 40.40M 46.53M 56.33M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 75.14M 107.86M 113.58M 56.33M
Total Liabilities 86.38M 134.07M 140.28M 82.08M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 10.87M -55.60M -26.95M -3.36M
Common Par 100.00K 94.00K 93.00K 93.00K
Additional Paid In Capital 194.06M 185.63M 184.35M 180.15M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -183.29M -241.33M -211.38M -183.59M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 82.97M 11.86M 40.10M -3.36M
Total Equity 10.87M -55.60M -26.95M -3.36M
Total Liabilities & Stock Equity 97.25M 78.47M 113.33M 78.73M
Total Common Shares Outstanding 99.80M 93.60M 93.49M 93.49M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 94.92M 92.89M 92.37M 90.85M
Diluted Weighted Shares Outstanding 94.92M 92.89M 92.37M 90.85M
Number of Employees 223 234 260 266
Number of Part-Time Employees 0 0 0 0
PLX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

PLX Protalix BioTherapeutics Inc

Chart of PLX

Analysts Ratings for PLX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET PLX ANALYST REPORT

PLX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs